MedPath
HSA Approval

CANHERA® LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL

SIN16384P

CANHERA® LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL

CANHERA® LYOPHILIZED POWDER FOR INJECTION 440MG PER VIAL

November 25, 2021

PHARMA TO MARKET PTE. LTD.

Regulatory Information

PHARMA TO MARKET PTE. LTD.

Therapeutic

Prescription Only

Formulation Information

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

INTRAVENOUS

Medical Information

L01XC03

xl 01 xc 03

Manufacturer Information

PHARMA TO MARKET PTE. LTD.

Biocon Biologics India Limited (Powder & Solvent)

Active Ingredients

Trastuzumab

440 mg/vial

Trastuzumab

Documents

Package Inserts

CANHERA PI.pdf

Approved: November 25, 2021

Download
© Copyright 2025. All Rights Reserved by MedPath